Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS mice
- PMID: 24555201
- PMCID: PMC3890793
- DOI: 10.1073/pnas.1321606111
Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS mice
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice.Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4385-92. doi: 10.1073/pnas.1318309110. Epub 2013 Oct 29. Proc Natl Acad Sci U S A. 2013. PMID: 24170856 Free PMC article.
-
Role for terminal complement activation in amyotrophic lateral sclerosis disease progression.Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E3-4. doi: 10.1073/pnas.1321248111. Epub 2013 Dec 31. Proc Natl Acad Sci U S A. 2014. PMID: 24381160 Free PMC article. No abstract available.
References
-
- Huber-Lang M, et al. Generation of C5a in the absence of C3: A new complement activation pathway. Nat Med. 2006;12(6):682–687. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
